%PDF-1.7
%âãÏÓ
8 0 obj
<>
endobj
xref
8 27
0000000016 00000 n
0000001056 00000 n
0000001218 00000 n
0000001266 00000 n
0000002325 00000 n
0000002360 00000 n
0000004831 00000 n
0000007324 00000 n
0000009770 00000 n
0000011690 00000 n
0000014077 00000 n
0000016637 00000 n
0000017184 00000 n
0000017360 00000 n
0000019797 00000 n
0000022322 00000 n
0000024970 00000 n
0000025083 00000 n
0000025166 00000 n
0000029791 00000 n
0000030235 00000 n
0000030770 00000 n
0000031213 00000 n
0000031485 00000 n
0000031780 00000 n
0000038406 00000 n
0000000836 00000 n
trailer
<<8A5D65579A9849F491E1EC15AEA0B1FD>]/Prev 52581>>
startxref
0
%%EOF
34 0 obj
<>stream
hÞb``g``c‚‰–¨€ ˆY8°%ŒSýÀÊ$ÁÒʼ
Â3—l�[ªÆyW€A9èÈì¥R�l‚ïxNÔ2ð]hJûÃàx—!j"ÃôåÀD"XŒ‘`ª¬…Êj1;Ãé+PþV€s!
endstream
endobj
9 0 obj
<>>>
endobj
10 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Tabs/W/Thumb 4 0 R/TrimBox[0.0 0.0 612.0 792.0]/Type/Page/PieceInfo</LastModified
/NumberofPages 1/OriginalDocumentID/PageTransformationMatrixList<>/PageUIDList<>/PageWidthList<>>>>>>>
endobj
12 0 obj
[/ICCBased 23 0 R]
endobj
13 0 obj
<>stream
H‰tWÍη¼ïSÌìˆÍ¿&¯‘‘œ8È!g㳓$ŽÞHWUÏìF±!@kÉáO³ªºùéÇ/?}üòó�?üùøô×ÏåøÓŸ�ǧÏ/ÇÇ·£œÖÿ×ÊÿÇq|ûøõñé/Ñý¯o�ß;Jü³cÌÓŠõc.?[õ}||} çëãig©1ÇñåQÎÞë±Î>V ;ûÜ7ú÷ãŸ�¿=~{´sôè²#–>mÇÜã\{ÿùåñ�ã×÷5×éÝêïYÎ=µf41f\ W8š±…~Î6:€û:>8°î8:@ñcœÅ@Y=@mUËÔ6',
`t�‹Ý�s®ã.«G³®hîXàúb¯ÁA{×Dˆ×vô-Ç7{`Q·‰vå*ÖøÍÚ˜-͉¦>X1±öÏA@ä‹m`vÖŽÇŠxŸ£âçU1�+–šq¸yÔ
Ú¶V´Gµl<êé£Þ=»;Ú1¶EÀô5Vog�ÇŠKj)´×D»oªuŽDc£gò‹�l§nw.ŽòÑp›=>p,{µ½iÁ4LåÁ… ÀBs€ÍrPà ë=fñÿ^ksŸŠC‹Ëª¤R=KìF-Ï~¶
çÝq†h'zŒhÇŠ1ûpÅiö@8C´�»x5û®Dä1q´+oÌ0j¶Nöi*°ôÃÅ4†©/©ÔlãúvõDÇ^À¸d†ß¼rTÚhæ ÂÂwlÞbÛíÖlŒ&(¶ŽÕCìA*Ã([Nй!,�wLK,ˆÈw\qªü–ðô ÎÜj/ 视訯‰?-¶G9óÇq©¯�ãî,þ€PñÁ�»]ˆc!�«7NUrÐ Úœ`PýMÔãÚžR Ö‚kÜÈà9�ÄÒ7>t¨Ú–&ˆé
SªZß<ŽOGŽ2n 3ùê«Û—GÅvYÏÀô¥#žafθrO#ˆñ\ç,&!ÜÆLlaÇ�ûÁsùéŠûì±Ûg�Ÿì Å2ÌcÈ`Yü-ᇤ
ØE+´Û'´±é?ìø?Ìp¶gøB1B²VoÃC‰á(oý«h1Ü®ÙçÌá+"��Ç"_€¤Øô( š
hÆÀµ3˜OÞÜIS/8ä
Ž&âØV÷[¯�@X hè\×��±\›±ŠÕÒ~zq
õθWl$4¯ýØ` ç *רi¼Ï…C„# šqÙ�ü¡ÁÍyŸÍI÷åC°úÂÿ'ÉØ.ynÃDû]’@—"Axpë)ª‡´’¹üÜ©¥óIa9=@ZˆØeŸ‘¹.;‚Ëg]»ïÔ‚sܤ€f#ðN5Í$íª‹üÞ”¯¢jZ¤sEÉ‘¶áâ3Å8t?D,°,ååõÂŒ\©2…`u9²´�â îC¾
P�:É’róT�t•cªfh6è«97¾Yò™\À¥}ucK›òÅ„ßÙ³¯�•vUXeøf<+l!XOCê/[¯þB<8˜wÈGÊ7Ð�äc•Q–%t}Rf{Cæ961½¬J8ÐÁà E°ž{B~…ºïwY}yBK»�<·ÞçßÒi%ÕV‘¹ÌtI”�fZºÅ=€RÛì`£Ï xAýeÝoù«
¾L(¦�Ct80×@e°ââ‚Ð hdÉzÇ”@Äúê«,vðYc”väY¬ |'P@º¬¥’t·wT[z±Éµ#†]™Êx€*Î#slYSù•î±™Ejç��,P˜n¯
“—gh·Ñu9�6N–"Eý¸èÖ¡0€í$·—‘€a‚tî>!(TZ–Á1C]¼ÜXM)Ù«ˆÂÒ'VKùLÇÜ•*“»0Ý’üËR;3i*´©ˆ¹Äúñ�ýy”9%xîÔ@¼Þe]®‚½óa4•¢9ŸT�Cr ¸8&v×ôŠpšT«Éa<²2Å7&•Îvåqä¶çÝ¡¨«¸Ø‹‹¯ÛÙªßÜ«¬/ÝT;=_^´¿*-ôª»·ù†ö°$A%áPjÒ(˜{ç&c«4±[*Óv>«žºM�{±Ìè ˜�¼æ[¯uégrŸRL-Y8-çD(~EM”eá,7žG[q%|в{ç*kÉÉ¥Ò’Ó^u5ö\
lƒ‘c®$E³žR¾�Åg/ìŽ ß³ÖÔÐ?UÉÃv*7&°:à~ÆÜ¦ÉTšSĨüxlÙbšƒÏ,BäˆÓnç»Ç$*)÷.×6u�[uݾ׈ã™_;Pü“Cæf]ÙÏæÅ‹Ýè"Øébs˜åE�?(â„
>/d¾x1¨xëÕ�2>ÎbÉÂú�9,Èfw,ÒÛbÄâéŒú÷E�{(~,ªz Z©Zϼê.§VR–}²4DõÁˆMåÆÙMi�xò°Uo+Y°ÞhÎk¬.V9™ŽKç=Tµ=-BTk‘Ò‹[Y‰òˆúð\p•J7ãÿØ® èYd"ߺTg¢ø”’6ºã©HøÚôäéB#�W§Fr3¬6‡ªÚ´#¡|kÜø%#�6š´šÞ2½Å7É8å-Ce\"»Æ&.ikÊÛKµ2íËKÓ�M‹J ûjN:³Gò ÖÿÂ;«,SÜßD}v
.ï…¾§å*¬¿â¥PâÔfvvÕÚ´¹&ë79—
C–/ª�ÎØUáð}‹‡m»�îs®»W´ç =T³bO:Y–J³¿½w›¨�ï\Ývg2U™†_õ$x^é¸%�6‹÷®ÊÖï/ýå:+þì«|ðÛª¡w*Ï¡øI¢0{Öâ”M„ÉãÄ�xf0BÞxu¾RÿàA´"õ¾ø B‚u¥õ2I�iº6”(0P&²1?Ä9Þ_Õ¼Œ@6>¶®•>ÞõhzJ&B‰––ïoe|WÕ:UDÔ½UMfÞ³I¥ÁLÙFĘóz îõÖÉš*¾seë…»å-Hþ\Å�”ÏŠ>‡JršHË·h]~¿#Ä׋™ˆªç´(?S2E\ɦLñõqë¦;ßs” KÓ•ï¾ñf¼k´Øf©W¼²@Q!€�E{Ãëdœ†Ž7Cá×{tw–E¯¼fYq%W™a4úã¿axI
endstream
endobj
14 0 obj
<>stream
H‰dW[Ž$9û¯Sä2`Y~é{†ýQ½À`î¬H*2szÑ@—•vø!QõìW?ýñ—�ùxökÛx<ýŠÁ?ü™£?¾¿ràÃak
ׯf5¶+ºkÑf†çŸv�àNÞÖÐ:Ë£ÛÕbc§ˆHcℼÆÊqøÁº~Ín»Ü;¦zþ±k�À!'Fçl,´kÎùè—õ�9Û'�>xþ^£Œ\Ø®n³LŒwŽÛØ8þµù÷W^:çíê3ÿkÍsz›¿ÆÍ±×__ÿùúûa�–ÿìqVÞhÇ:ûò¾s—ß_˜ù�3cå �-ì1®±N™ÇÓœn¸©Hcù¤1`ì}tmë0£wεý˜WÛ£�‘|Ã…éûyypC\tʱiXOc�ÅÊ:|N†zæÖñ¸¿ˆ3¹(¢—õkcîl|‡nc°:O1—ç»åƒr¸04Ã'7Öý¹è6~¾Ò©xÀ�ÜAŸ?"+�G|ÜB”ÆvdDãï¯Ï쯙Ȱ.®M¸5}�ÓýêkâY¤„e`|Æ#ø(\5iÍÀÌâ#é×n¼î:\µ§#Á™=ñ,{�·k�eØj'à ,¸Õ"Ç"$cŽÍòÿÈ$ɳyOùyÙ %ÀÖk´kžcÃ{Ã�ù�˜¹€ßybî>·ü”91ø†oÞâ=ѵˆÖÎ�sÜ1êåƒèÓV@à‡À8ÝäÆ µ^c„/ú.ËòÙ§˜A¦ûmw®Þkç„ÂÁc mú+/ÝèM@,ž5’–T†UFF@ÂÂ-€®—O3Ížñ/¦p&iò`äþ�¾ÿû‘Õ±’’çVæ WV7%ìVšáWnÍ¢¤qþYú¹+Ñ·˜ÑÓ‘ ÈQ9>2dü?3DIe '|‘—±å.=éC ·ÿtð®‘[Ë5¶ø˜Ý{h''qon�&ßÚÑý‚|{x[¤ÅÛ�q)ì4'—Ú‚£‡ŠAú)_|LÇï†à„ñRÃõ&šn{–Á7”5—ÏÏÀ¢ÐOÜAyIöc btõàßâãœd(
Y’ÿÏ?š¨ÌdÏŒZ‘€Êoß4�Œ7Š€IÎιmðä`Âý"泓’ˆÉðàͲùiÞ⹉‚øÀ3Þ6B|>–gŽbþeg6ž<“ ¸¾O‚=L„Éz)¯|_2ãêoøõG‘²vòõɱ+P��Ñ7žó”B0Y½ÀØÆaEU—�£Ï$šÍÁÓmð«ÞP -î2»LŸÄŒ#¡Ç&®Ç äý. #1²ì*‘öÄB
ÄÞÊ Œ´?çr¯�¹%Øãr@V)�3�ª$'I1iXË·ì¬ûà¤4Æžz®Áš›WÈx,]²Oç>{*ÝtÄ1¦×jµí9ʬྡO|qߘüq7×Z”Vˆ1¤ƒ¤”lX³�Z+{í«/ël;HGZŠC“Ó7ÕV&r¡µ[),rÑHXp-H'Y÷pÛIPŠèá"¾I•‚ôÇvIãÆ]Û>·¥ ´—
Bx¡è7×mãõgÞÈŠý–´Û±R¨^hYÔœ§3XÓ©FÇî
]yj©w¾a#×%.½q[ÛYÝ Ý›]�—†\o@(òJ�3!Ç
€Š~2vÐÓï· V½‡‚é�‰û�ŠAj\+J3ª¢¼EçN©±UbM›ÒçñunYƒ;5ŠA"ùîŒI»kÈP̼dòdŒ*§@Íi;Š‘Ã�© xÓ�.’,©¿ßVIö�I&G~'˜OÊ”ÔaÁ#ùJ¨/RàÆ9Š«Éë úÃë4�þÂû¨ÍˆAk¨.�Ki›È@B�*šÖÊ6åËh§Ã¾[MGTˤ½‚s©ÕáÝé<ðŒ–.™#–2˜n“K}Aû^Õ‘Ëù¥¸QÁ�eH”¶_n5JÜ)“ŽWršß‘Zm”,Ä(ë–xýôQ†ÂO-]s@;´ ÕØ=yuÞÙ.fÓÆ£t'Ÿ˜HˆÒó¸é� ëjœ�É�ÝÁK´å$ÿÆjÖÇ=®¤ù³¥Ê÷å×Íð|T«¼$+üÆA&—Œ;™d·üíPÿmžÍÜS.~CùÂv£qzÈ*Ö2 ©Nx˜÷Á§¢ÄøÂ/›:Ö—ž‰VVÊ
K †>±a÷’Ìæ%jA¸�5”z}Ü’«½ñ}°‡ZlWcR¬’<ðk_ºì2AN�©Dç«e`�æ:#!é;oe‚šB¹åÖU3!Nq³(ÁÖ´°3µN_”=>-´]µ”æâž'ðLª¦|Á›€ö°'h w™x#ZB@”·,éÿ^¦Q»ÑÆÝÏ� •
•’ XC´Q™RËýQ?7Â�ø¡Dðj!ö¦Â4* ªÝã•RF7Æžr=àç*7Ä¥ŒÑ³&±Ô.´FkKíK›Ë¿”ûëíS$uüÛno'cÐ_^æÏçvóS:ñåç§ ^Žf¹Ý·§ß–ßR»løšmÆílÔÇ6_Þ~JøÑß(»Ž›ûº]ò´þš öÀ1Š ŠLÒŒê›CwL:“ëf9{ÜêE¢¡‹¹�Ú«¡µ¡Nbyˆj+Î"+·¨>ˆdoªÁˆ¥
Ž€šréò(jL2GdVŠ)>ätJwµz]U:èÅõ(¡¸¨HuúÝw`i˜ºî&¯¡©e¹1J…Z×AÅ*‘ò˜SgŠÇ䬱Ëü¡©~k¨Ú�)O¨h“mÎ-h ýq$I“]%
d¯§há¾_¦ýk©ÎAxP8'}¨™)ù‡úš¥/ú,}}3+°xö=§´1i<ä&?eRõ«ÆTeëA~=䵬qïh‡µW�ŽÑùK�m‡õ®W3Ó„N1"ÛÀ{{õ„ßÿßiõÎægh\ýÙh
}» ~½Û§æ•¤î¤«Ö•ªxÐpåø8e(ï,î9ã
á•.Ñ
¯ WäÂÍpœM¢ òÓõH‡™¼ª'é}H3‰\Â�ÐÝHI¨%Ø®HI§6&öTÛQÖ‰Bí’àù¥ùr�bvw*\k·ÖuÙEÐ÷"ÜKß5°ík‚àNgDúÜD Z•‚Þ&·žùºÉ›ˆ
=¸ß�ã„ÚN¨„W[ÅÖMBÝdSàyžšQR;1 Ùy‚ά´Åù©b�Û+þjŸ\õ’ô�Òü¨õPãÿê‰VHO6jóÑÞ-êJáU�ÿ 0²y_
endstream
endobj
15 0 obj
<>stream
H‰lW[Ž$7ûŸSô¦aÉO#g ÈÇìGîÿ‘TU÷î씺\²,QýiÏéöø\Ïýø´ç9�Ï;ÿø³·uY_iï6î·ýÙ¶ÃZ'`
£—鎵ý¹GÀîs>>dz¿Äÿãé-›Ï³�–Îq`[¬Ç7ìv?ŽÝ|Â�?ãðÍ:«Zƒž°ÆŸ³ü" ¯ï`äR{F-ÅKËè¸åé<õ\üp÷¡µý8·éxé0†>4íÑ
+[Ä•–vZçàxá|ÆãÚ[ë6¢Ï‘;¤µæ†eÈcZ� <1´v0÷ÑÙHsŽßì =YüØø±ÓبòòtšÃžýàm´k-ÃAšÓÚ«òcƒÙ>›ñÃM²"iŒÜ5tœ¡’ner/ž¥Ñ
àG4VÜoýyƤWÓ LÑùúæQLç›xëy¾u[é~[AFö8|;€Ž< ¿ïˆ6Óvʧÿ–Ás³6ÏïMÏçS‘®ÌGVž°O8XVŸ�kƉ®Ãï1þ´Éís§ÄÙqmîe0õkØë]Ÿ±
Ö±OÖ±rˆÝð<3Uù<ñlô–VÂ^ÖwZc`'¤ÿûX]·õÏÇß}üû°GËéÁ²,I6LÂ2Sùõë¯~1Ä…�,³ðý�´?â9¶Œ�Ffòÿ|öLûÌdè ˆ7Ÿ
�;OÜr/ ™GnI_£P‰X3ï3”´
~å㜱´Ð3-yÀÉÞêHÁØKµ
djW¢�²^k³&nc£½Ã`ñäŸïÒ×À»e‚ËŸlkáaÑ݈“–[§«Iò̹cßBMx×Òûž:®Øh3„‘0Àd§Ÿ=¹omqŒÝ³Z¹%
'J‚~ÃC°¤ß˜üq·"å8lª6DÁ¶îy’—U-vÛ{ȯ¾¬M¦úxUÜtdÚÙgÓšâ¢ÓÈ_»�¢áÎoÏâÚE’�C·“üØvy�¬lK=ÉÉnôÚö¹,¡Ý69šÔoªWW´qÌ9i«Çb‘…Ár@ƒ8ZIò8‹Ul:¶?Šz3•§–vçV°r>^C1�+ú«Ú:ƒç°X/@¨òj�3!×è7M4ÐWvsØ-ÓôëeŽÌ/;t´Ó›øbˆ$$µôY‚j«pD:æ'ÖÂPÀÇÔÀPj$=¤e
QNãÀò@l5ÉkgMšUë
Õ¬+Õè=ÌM¥¢m�c;5Uƒ 1Ò=)-ÌÉò¶ü²“éo/Ùùݼ<�†:%Ù]Z�§ìH)´'z¡y©Œ}Nè�fõi 1h�à±r¶µ£Mœƒð‰0VÖи¾mS4QÁîjÍxÔ,
dô"N�×ÆØ™<ðŒ–.™#4ÿ4àÛäÒ¾0¹ú^ZjÁª·uµŒ}�|Ai48 ð«çïÔá�½§žQe²Ämzã:aƒÅ-0l�;ò’‘Ûã6lÏÃÈÂ9w[ÓBg½�/Q‚æ²bÜKi.ú<áTçÕÖHx#Y¼(9Gb™8c3Ý5e�·ÈÛ4jÎØHA£÷s¼>*A1\RkÈhlqêec>êçF8?”¡]—tT:{èÞvèŵR߯>•zÀ¯KÒ—2†fMBu5Qc"}½^ù%)®WN18âw»õx%™—Î;Ëüù\iþTçÝyþÄ+Ñìí}eúe)Õ/¹†_»’
ÚmóÎö§.bz£¶½xõu¥Úü~Ç
Ç*bPý’ÿí”shÛÉdrݬd�K!K˜ºñNyºd�Ö´¸S„ÆyõÁYœü-8¡)/sÔKç¡–5ý
Ô”äo�‡àè+§Ìj± ŒåcæRDwÈP‚Á,®GQ'à"!äÌ[»b qN…»ÉkÛ¶$�QŽÖ:Ǹo¥vxÙeÁ:ï2â1%kì2¿i®Aê‘¢!Sž�0$ÛœëÒDè�£+
iÒ%ƒBóS÷J]fdÊ?k›Í >stream
H‰ìWK²$'Ü¿Sô¦„@pŸá…^±'ÓZãX+´$M»Á„¼»ø%•B4´&ZÑ©áF4lR™rL]ðpK+¼yÑŠy�c`ò¬ÚÛDzÛý8§m‡SwÚÜ.‡àÒ%‡´´kNš‰}‰�‘ŽŽ!!¯)´†|¸äoaòLD¿„Ûæ tY[41�׼“á`˜ÌÌØ4ú¢éa�|·eywßt0‚SFW0úbUÅCÌE°fÆe‹ñª+øw¾ ºs`S‚Œø!á×
]ù
<æsFÀákh7vŽù‚âQ•pø3e�Û@jÅô³†ðáð†´Î]unCGã¾bX¸ŸrOÁ�àÁG27‹ÎïRD"�ð§gà‚5ǧˆ`á±Sܬõ�Ž”¡,kæÈ°Ù®5
gx†Kæ!¢¯e®Ø¨@†ÿàÆ#ŠÓ;A{£5 -h�Öƒ¥%]Þ€WaÓä�˜!ÒØ
]7Ì®ßÅSŠˆIö¾n¨-u%U�€yÇxî¹oôŒr-U†âÔÈ33ͳnüññÛÇß/V•‚ϨLàùŠÒA/tÿD)ÁŠ>áeñÃp�•e(\J“*–DÖ
‘Ah2¸ÄImì€ìPŒQ¦²dBG'u%jÆQídOÙ�V ޲J²¦'� ËË^§k�]`î>�
¡æM PÁ62Å&v\ÊA¾mµ\6�=¬/õ¶õd°xhꛡ
¶Ð”‰g¡«Ô¯âç<V©e•ªÅ†zZÙsDD6�fé86#œ¶æ5¨à¦œmfÙ=)š"ß²
ÅRÂŒ:GRHr5dðÛ$7P´qä²ì•‘î¾{*3"K½’�=˯
¸ìasò÷ŽzÕ@›-9Biá9¨ùR…ë�™@¼w•leWb·ÏRÜUç®ËN5VQS‹9ÎJ§+ÿË|ô·„WHLP>T4YоG;�¾~®ñåXÿÐjë]ÿ4Ø¡IçŒIeˆr£ì&˜zR5Y9\.ªÌ#�žÅÓŠ?f¾kŽÉ$ó‘Õ¾ªdîäî9_ÍŒ™_óð¯yøÿ;¯_óð¯yø??ÏLꨰڹÁEŽFžþó;dæ€_(Áº" øçšL“ÀY.lu¨>sB AÜÔÅ¿ûÃQEY� 9JVda‡ø£ V£VN3àÿ&Ä& ǯ!(Ìñ\/qí…f+žGTÁq_=Ðvn½.Dµ%,Ü4Û\[9l�ûh°®rt.F�At]ZÁpÔ¥uBIO8ëZŸRðÚ=‘÷ýy8)‹ûòCèVí{Â?á²»É/fÚD”…:ü|ã Lê+ÛrÀXtze@ºjNW«äsÀ®•¥ÒäzÎde⟠ÐXì3ÈÙïØhXJb¿¢¼Il™º�UåE¶=`jÛ�㨥þ9M“YÑLQœyÖ²c[4 ªÎ'üôlœe0 ûÌCTu¢ì1£kßlYâšf®%AóªqìžkXLXr9!"=&3ŸíÆÕ÷¡{§UN´ÔWÇ_‡ÈŽ::/"
Œ�$ÏqÂj‘.SùDé¶ È§ –àÛì„ùö ذ“TŠKÍÊ‹`ª#�-§A$§ŒÈ©,‡û¬)Hˆ@‚·¿ lû qàí4`;~GYhU몞M€M®ZX±,¼ú‚ˆeÙ6RL³Ô‡›:Ú˜ö ¿vyŸ�Mrd3mF5îùŠÉ º£kè³eóž®·ß§Ÿa*v8çTUØ'jËN>× ”3óÏö;TçGÎøáÑÕ¤›‚…�Aß{vçò\-mÃC¯ÑÚÐ!û ’�ß1Ù|`ö›l¸§v–n²óùs‘�¬MvU¿L²i«Ýd³…\dƒ¡›ìrFû${ÏzgÍ/²9û�›l>Ùš3â°Íð`›IÙÛ¦›?ìðñ:nÂym‡q"Ÿ‡ò%çšÉg·1Øõ;<ª®¬+¤9Ò[Ý¥åLÉžgX³’/\vå÷ë_Ffxv
endstream
endobj
17 0 obj
<>stream
H‰ÔWË‘d7¼·å@Wàߌµab:´»þ6?dU$Ñõr ‰ð]žkìGyfÖÇÏ×7`mü”Qù³ÊæOíü;wðgÔùøÅ¥sjéN-�‹âgQÎzÖÖ¸XÇŒr–-í?R?=
þýúúíë__ÿy„P<¢´çì93Ê3úž|ñÿ~÷gÇf?~œã6%‚`ï$à�Æ3±ù¯/À> Ûžx‘{ìE°kja.|7q!ú§•IP·ï´z>îÄ…3{玻
\·Í<Ï¿¾âÙF¾ÞŒ5üIX[/ZÒWù,[Û%¼�p˜Î
ŸX1hàš©…}êbŒGbÇMPû˜C äÖÂÕåš’xÅe]žös{îÞ¼
÷„öÈ�'úªÇ'œ»?df€(<�÷Ø
pán‹ïxŸ×qaË ±°°ÂÂuáLØ»ji¥¥{è]AD:7œ}ÉÔ]«<6µ.§ìû
"óÞé n?s;ô‘Â�í¹;YŽcq5cN12xƒQŒt^ †ô{ƒÑYÏÊŠºÊ�!$üÖ:eøS9R¦î¶ºÒ
'ên§Ô*¢ò†ˆþA†W2.Œ9ÜL4Ú�û15¼v:¼¿ÿ9·¢‚Pë1ˆ“ó#³TÞYIù\ˆ.i%ϳ½•¯7{rUôij÷` š2,?P5˜D�{¦")›¹¯ða]<À�6%
p\UÒ‹ò|…�äò…=ª’’~„¡£¾…iþÒ�
/–1°´/oÇWd‡Në»U¨VyÀ¶ðe08–õq›éRÏ·û¢dã3e”ºI+ú³Ø-ñèJ»«?ÇX/GñÇh lt^ÃYN7ô¯¯‰xójdâá
rWÂsï¡eÔ5¯¨nâÕ& ªA€Îº…;}#FÃ;–€¶êì2½p˜¿ÁTçþ‚˜lý
ÜÏÓ[ÞŠâÀªPm¼É)ÒØG0=¨—^Fí£ùؽô
¶+úL&£7}çºð®5‰%ªC£öŒÙÎua»q_|î~Þâb[ä·(”»¨ò[®} ÏžÍdi²p’T³êŽ¥‘Âî"ÇL‡g¶ØÇB –÷ÐÚðBÂëÞ+OŸè:û":ÏH¿ãl€Þßάig;K�³Oñ¹Îô�élV©ëlÞ5ßÎŽ[±élxèíl÷/g#¡ÞÎ>UTÎkËx;Œ~;›Z:æõ6%àÃÛLÊ^�»IxbŸÞäåpq=ND¡´ËßÈ>¿øº™žÛí¯Þñx„ŽŒ-gÊ8Ò"õOw´\|H‹™
=ÐÈW~ÿ3ú±„À¬DÍ@W±`Å«hÈœ¡BCKð@ìï’
«ÇK@鿦+EÈÀÞ,íÊí¨ý¸QµašÇQl¡^M9½tôi>)3–ëçþ@³Ÿm…±û•Äœ?Ö¿:eÉ–H3ÎM™.3‹%åh‰¼ìLr%_ýãmqŽÇ¶¡Œ+¸‡©£êÔe›E,”'´äÐ?míñM¸ÜO󣸾µK‰bégóbÆL?´Ícÿ2ÑÐ&¢ÀšSI±—JtÓ}Øõð ]µ©#y§oÃ\.K¼Þ+ß`eœ~;/)Ôî 0;^µh×ÙD
‰ESÇ.ó75Bì[´"Ä®ïû¨˜‘¹ûõ6]Ùn¾ÃßÞ<¢íM•ú‡n¤ú^kñšxè[ôZ$êae1ÜŠws7‹Ófmˆ°€ÑeŸ¥Æ^•ßÓgvçøšÇ‚ª‘¦ÈŽìê+L’
ØŽºº/eúm¿v¸2±·GÕZæe�lÖÄü¯Ü]Í(y€Ùƒ8þ¼!§Lw¦EùÀœq×”¡þý�é
ç§$›v¤2SÏÜ#+Û}z/ÐÚªZ´X碣ò»’&Öàøãð”Á� [ÑŸ¢ý»†#‘N§Xc3x
UÝâÁBÇ^îŠ5~wË='×
÷'5Û–êúzÇfmð«½n‚}չ¢i”C´*·(�Ñ™M
ƒ GßžWlŠÆdÏÜ×VÝÍ!§W°†ŽÆ}.Í«ˆ˜�êþ‚³±àרvGÏʼ#Ÿû©êÝ,×»-e`kŽP93³Y7þT*6g!fAXmNlÒ¯¸íÒNÇL‡w áœÆ÷¬}n“
Êü™£È« û[¬‰ê©…kqá®§¸»A KoÊQ'µƒ÷—®p�$Æðqï½·cQˆ{‡–y�`#¶ßâƒzmÇrÝ[Qfâ}c'òñÆ©ö“Añ>ÝÿUâï2ÎVdjO IœNgxÌb#´dþT’
f¼
²S7ÄÓZhÌJ›>�KrwùYÙíõ&tG~qÉë½ÄkÀ欟c)
ù2ˆ1^¶Ô±·ý¦Å½™ã;—ãw#ßæãR_÷ÇYhôsŒYËH¸(v\Imší¤“žâ$�•„YÐ¥#è/N¤~ÖH»Ûë
>ôøÀÑ”ÿ�«ž–Ÿ[)jK:8›N*\U¦›~á0Í�Á¶Æ¯†Ë�‹¦Ô VªÌÜûÐÿ>—áE[Z4¤E³º%ëØùíþž›{Ϫ{×4¹‡¤i©¨¥)Xô�;dŒ‚¢lÌ· àÛ)±h‹¡ç Àjb§@ß¶B¯Š‡5í:L:3ø’œõp„:C��À_Ô¬rž~øÄ‘mSë_zel½ŠºÀÓ
‘HIæÀé•ö¿ÿÆšEkèlds–�BöÙâÍü+â)ÌvÊ q[+Níõ¦†ßˆÜ�ñjËîH«…ûç|¤VQEy/—Ì»¹@5E‹
{ É~ïýTù”‹.µ~×\ÆBœwƺ}ZsMvW©¯ÆVc’cÜŽËXxn‘ž÷�þu�j}×WlHı®º²Á)ýÕKÔÌÜ1nå>ãÕúl#>ñ¨Íã—îòî}Î$uZC·%³zúzÍŠY^#$¸Dž½>stream
H‰lW[Ž$¹
üïSÔ:¡ERÇð0ü±cÀðýG•YåÙÁÓ)¥’Ï`è»]½Í×w»ææÿctþ z¶°Ô¯¶òõól¹ˆgè
7!7¡œF”îÜ‹—�«m>‹¿‡‚Õ�hæ¬�I¼Z½�!äBFC
aï¸|æÇjŽÚkøÈ¼ZÜ9¯¾õÛ�kÓê8'°¥Clxmž´«ã€¿ˆ›üêÙë]Œ:=o s†=ö®sºþäTwå¦#2m�¾fYí5†²áÃg/�@œ[–AîöêHN8°¼>0O™/¸‘^p" 7ÄYñÞ;dÅÿõõϯ|ýçÕ_
ÿú«¯Äkq4Xh
ÖüúâÒ/åià>`WCV¹XeŽ!ÔD% Ö|=D ÜîÇ{/â—ù ¿ã~�‰èýÁ˜òÃ�9/°çwxlí(•�Ÿémë½ëwlWæ�õ‰Ñ'óm+Bõ>>³%¸—ÁÅ@rÛ]Ú—ï€G
K{„Œà¨v-'#Èñ r¯búaø–½XÆðéʤ¹7¾·�jTôÂPo¶=^•µžß�´È¯ÙýUoøµñ~�—÷ú"¿’Šl}=¯ÝòصQÆ[»d1bäûU®
á4cÓ‹>ômâ★ŒöÓöøïí:mVbL`ÍøÐÎôšý0¨ªm„[œƒ.IØ�K¤%a›¡L4ÌF+íÛ ˜}õÕ_l¥
—' {‡ãá�]øì‹«á7ª×Å{õûb!ƒáÚ…7ÿÏs·™vñ+p 1•ü:×÷±«zƒvÑä
xùˆ•“âçŠ
ý½¾*0d�Yü×mT´E,>'0Ú$–"%f‚·
óGeÚx÷2dîõߟT.
wu†g"ÜtóîÅ&&Ça]ü–,–imšì÷bËÖäYQ±Á‚³¤çeˆ�=ï%pÍЧb›®4�õH–äTA…:ȧKíˆuíC²H]vpmµ(õÛ¯.0jÀ!ÃCái¤uG„8‚�^;BϺç1Åü™úz˜æËP¹ÑMŽ%wJŰÕzYïë‰ñš.œìà>Mo ês+1O\Âõw„iç 0›Eëüj,¥"·?“°d�Htk#L¡C[gT^ð.ÞÂAël‚sÁ"™ßPåÝãý€±õʲ‚WíE˜¥ PxYÛC]ê²
%µUòò®;Í}/å5+ S±vAGÇY¯ÌVL�OÂS°úTý˜8P‹^‰,:D�ù$aÜԡꧬ€C‹&¡¦HÁ@%ømWétÛÏã�‚’æc‹¨å÷\æ�® ã�¶šð›¼”¶b´;é”OÔËÊç¥B¯Ò"‰JÖNߧºKîFVôÇöÌó
ñÇûÙ®‡[’ê‚•r¾U´Z¦ÐL0—¡>©&Z(€$5Dsù©#Ð7J“m¨POÑå@|ÀÃmëQ¢THÈØ"'…ôwC]é-ŒÅ³†
k”(ÖëÚ€:Ç¢¼pè=uSiZkch`ÑŒl5ÞÛ¤[IõCÖEÒ·†!¸gn/If�ý�ûå2ÕÔ ¼JQâïâ-!o©‹ û¤üo¯3i–kZǬØ7]šÖž³.P©ÕU×�z¥ü¯BBöIûç[W°Q—‘©>ÅÀWæy‡qŠv1RkÓȢϥ«“®…ªIö|VŽ}¤:ÔÜê-NW‹qË>ÄÝemù D~íÊ61ü#ß“À¥#CCi†ÑV}?-”•ú@Ê`p™d3¨ká¼—(éôRhرÜ`Õ0ÈG×Wï‰�&"ƒâq~>EÙ³¤P»Ñ¾–”Â]‚¥žiý¾
iºr§;ÌIÉv‰•¥À¡"qÌà
¹¼¦¨Õ…¶D—¶µ~Cí]�"ÔJ‘5µŽñçLæwI»0š+Q`Ý•ª6&Œb�SÙsI9ƒóBä¢+áÏW¨Ú1
¯D£K䢴ó’»üùóö[qPW±3šN½nóVnèÞ!�Ñ$톪‡ó“ÕÙ$v±oêzsM\U/Áßïó@Åßß ëyðd?öu\ú½Tb‡J× ¢?9MúžÔE�/îº}×@È’–/ÃPÀÊzRJ/UÐ4.*ÙÔò[\9(K/›V¥ÌJ.¿‘4À¢Õ jD4D�§”P~¶Ž(5¹uªôÆm/Ô4|÷8^ù8Z•†+¬ÃÄþù’!Åä,RaK+ºËÒ£ªýƒ8ÚuÓ|0¯3ç ¡{Po³ýð»¼ÑyÞù\’£™JÏ)µÃß«¦h’¡(»b¿ÉŒbjÍ"ÇÍ«å®QºxcdL*¦ÃNiIjðn@5æ»4¹õ®–‡¼”ºäÅ0]`³t¸›ª7¢n&¦½ý¨á;¤p•Ù{pV†LOXãüŠ}Ã$<FË„’JKåá@4E\¼¦1²©•(C\QØèÞ;lÐÉí#¦K18ðŒÚ!ÚK¶q§�ŒÃ>ç8‘:�b7Ífý.NÚéŸ^Ÿ{ÑÇÞ^ôM’Œp¯47«ËØ–äÖç²úfåÞxï�…Ñy+ÃQ-Ã.„`p‚™"j8ê�•¦ö¢Gⱺ4Ð(ØlÿwÛ-C8”–š¸ä,¼.Y"JdØËú® es«¦¦ØŒybË®îõè”ÂÑ¥©(qTð#*ÂR^3÷ˆA·3»}ªn•«V;gÑ%™Øª*l²—&a)µº¦®q¤ZÏ|V£%¡=–ÊÒ%š›Xˆo¸æWÝølS$ŒCä™uGD]UÐ*A�–ݯ <ÄÜ-�¶toDãébSz“Yb‰nÊ9¸\\€hHKË©…Yp8¿Øh;ÏšC—<0ß•Ku¨Ë¥@ û=Å{´g±Ð_oÔD)q
iœ×Oˆ4ÏWµ=GƒzHª ¨—4™·rŒycÞü¤hN̪¯x®qÜtƒŸ¯×ÿB'|7
endstream
endobj
19 0 obj
<>
endobj
20 0 obj
<>
endobj
21 0 obj
<>stream
H‰ìWAn-¹
Üûïnˆ¢DQÇȳðäþ@ªŠê~þ3³Ê:»ùZ-‘Åb‘úœWïëõ×Üãõ9¯å[–wþë1øo´|}}àaéeO}.¼LZm
Z±S߯ťyY—=Ò^°~†ÕrÓZŸŒ+ZçÚ}5ë´Íðó¾lÌ×§_ÓÖcõÛh©L»"œåÄ~íZ!á×|5.[×ÂŽü=èáŽþ²«Ë÷æÏ±uò¼‘õ«mçùm_:ökvç:»V›0c�›�ëÖt÷ã×GýÚ}ðl¸ïØ2Ÿg›C«Êððû±6öáÆöp€¾üD:¿k‡•™ÆÎÝÌZ»«é^Á²˜OÈë„솻4 w#¥ð5ûLE3µßÓë—P¿¨Ë“óðÑt«š\êJF=ß—eµŠ�öž5ÆD”@oU³
ùbeT{µªl·ê[1ÞxüAÞz•>‰ðë‡Ý%±ÞF•MWUWÝ-HóJÅ*9æ%ˆúXŸÒÃíHIÎj½ÄÃô‰FKQ¢qJ„WE^ÓBM·^~[Å,¿MÞó|†-zo‰Ö¼Ïãõeß®À/��ÇON ëªwV|¦+É<¾®®Cd¬p»Ne÷O š&iSgêÝÎvÈΪÖÑäËìûU.4MSå]{Ɖ¥Ôs:«ˆ°6í‹=¯Îµ‰åhÞØ•QB4òýŽ�×G'÷~'YuÔÉcùp’|»wPžrTH‡9w´‡VÄ!\!ô;µrÖ•àa'm,Κz}œËž.+Ê»&ôs‘�/£˜%?³=Qλq)Ø¢rºò´ŠçSÓÛ<0ŒE,ïòXÌ5y€‹¯:ãuŸÏ«éá´g7ì½ýDHûñ€(çã):Žß¦
®€xo}B…±À@jj8£tóæá1Ùñô ÓlY{1Ö]Ëz™¹Ä�.ÀšÏãÑ;šž% ®ÖÕöFËŠ“ÏYƒ28÷Ï‚†úG%Ç!ãÚÏ}>9Yxö;):g�ì7îaôöñäýðùd‹±¾<�2PÞ¼Ó€ð¿þÔe¦´À°€ñŒŠ»ÞMV÷<Þ7Z·j>
í
ce�"¼÷,·‚ÜÐ)4éyü´JcÌ5a~Ä¡oÍ ‰‘ÁpËm£&νªËïßlµÒ
fà†cê6²'š5.”M‘1
A³¦%†¿¸zgyϦ~H¶#iù²²xâM´Š®Ö8‰q ùûèµqÿ€“7ú’ëüœ‚¯Ö4FâîR†
*Æéd&¤‘776¹OLÂó¾>>˜pÎÜñÆämsÕíj…•è›ØÅŠÓt`¸{‚À;{˜jüv Q×Íhh€lVWŸ!ßbs’¥JôIj¼^ÿùú×
ÍNÿãÿú_(ôú¯¹dwã
endstream
endobj
22 0 obj
<>stream
H‰¤WÛŽÇ}çWôC€LžQß/€ @×@†(�x¼¾¾Ym—›/×_<ñÂ9W=zdž<ÃaTRÎu´™ƒ¯p<³|¿øyXÚ1˜áãÆìVáÜÍðÅf3œínvfm/.ñÞ«¯‰Ÿlä£3/`H‚šáKñu.7ïÍðÁ"‡‹+ ª¯®±Ý›—ÜæÕOvŒøüwêbÒ³—æ�cÃÊÂÃg‹ÇÙù¯²¥y
i3\Yèsñë6Ÿ<wßÚ(Ø€wNžÁÆÎÅ‹9›ç|2i2é)æœüOÆ"üö6™Ogì/ËÉ[ð$FµÚ»ÍùÆŽÐò‹•º]›½4õæŸeýÕÙÇÁš«w[9ÐÆÜœ[„Þp�/Ð×xÙYÕ} s¢EÚ¼¾9=G³¨ª¢Õ¨¾„jMU“xù#ñ�…|ÜÅSKü_ž÷â÷xìuªú»ø�g‡€ôüÂz±Ô†«|1�bÇ,OÙãýmŒÌûs©ë³Íl6†Í_Eä“Äl;ŽØ¯VÜ»‘׫+YJD.üÕ\ÜØÄ¸óˆ·øS�>ˆÛÇË‹5þcÁòAý{m$ÚdG~¾¼8W¼ãù„2g5_¿._‡ÍÎæ =;î@ã›+1èÁˆ—ä\W)ðÞB›
¤\¦¼ºÿùrñàõvµÞ¼ÿÛÕêòãÙÚ<¡/[dä{¬Wœ 0*’<ÒÐ?͹涨¹Ý-7¹�ï&¢ºÅVoË�“‚‡Ì%UÑù:W-&YI€9u¦_bȸ¨�(Åó·ŽR,ò¨
{€¢æ»VpÁHêM¾²¼ã/BEdXŠ5?÷yUÇú‹ÒÐY•Yž0”cц
Ò!(‚4˜˜Óíg¤)î3.—É~.ËxÛyQ,qÊ ë¥Þ%ÏÇZ/"Êj8à-°¯ý€ãA3ØûpN%v2IFГS|s9ÑÅuõdkEPPÔRädnŠÏ«–Ýí!û *ŽZ™hØ\¤¢»öH*:ýºÿŠÞÅ‹õ]MtpØŒA«Ì‚Ü;º¬§Q5\_©OáŒØòìe>ŠÅX¨=š€*þ�[ŸZšQ‚yöO!J,�6©Îë¶›¥¸ss× ²†,·k„¢élü”Ò1Ê=Ír"û½zè±^(BÚ½ÌQÔ`œŸ1î0»®¬ãö
·{ˆö'àDÇ8VeúI6Gè,È!cF⸀ÖpÆÒ:%w+�ÑQõÃJÄ}d.ñA�
²¦cHk*d9XÌ· Ô¦¤$dk¬Óù rhCYƒë+8ì®p»‡aÊÞB§I�‡lÒ¼jeIp½t£È<X†6&ékÕÏœÜÑ[Ñõ=šj�`ß0µÙ¼Ž‡B+£ËC€&AÖa7¢±c»Ü½¶�÷ˆ'J‚š_@‰G€–Ø7�ÁW\%"…‚˜Á¡µ–k€LŒr¹pÒ Íƒ{ÜHì�áÎÈÃÔcn@'øÊñ|b¨ùš’¦ÄÌ5ó<箽²\XäV·v@èò%²÷˜ÙW-šÓgœ/.©Ü"ÚÁ3¡Ì†¢©È-¹J¶e׿^ „Q-f_¹Éy^LˆQ`�J9‹lœqÊxÁƒ(#È5z¥Ž7¨[`ܲԌ£ÜCXZªd߯ÛO7Dí º0'lBÌ"˜œT¤Èfô²DÄÎJ ^xôBkƒ)Q2EÒ’•´üÕ=�¼n?2+† jIŽl^¸•å>G!‡ÌpX9E!n“¼aV–Ó,wN–Ûêeƒeaޱ¦ï*ÖšAŽIåqÕ@hd-¶HÞ‰()=1�ïrk,�I¬”*—˜xò\/ô>Ân!I{ƒZ†F_Žê-®7̓…‘!PòžÜ=£l>2g=ÙA)ÁÚW´ÂAw»™ŒÄ‚n‰$ÔxÄ®D75IWŠ�uªð¶ÐÓIJr‚ç’TPž¯V‰M6VrÍ,¼æÁ×p<ø»„AFþAÆ+l#E2z+ªRÿý]“ödãT»Ü}¹¯~'�zp/b·rPN@Ï„4¬7ÍÓª‘gpð,Lè™Ì‚ŒcÔøLò�jfY—“ŒÕQÕÏâêV‹¶A‰–;Ò™¬`ä&i ó=�K`Â�].§EÛé=%gµ¹ô1IŽò^‡€@)HSá%¹î32H”ŒïšµÚ$åf¶gEr�“¶‘¥u
¦,±û¼§FŸ‡}·>xé¶0èŽÚaXFVeÚ/Ú!…厔MIбH
œË8QªnRÌ¢(ÚJS“W47rs#Ë`âaZSßÜ?Éw©€BïSa<åÂxL†ñ˜
ã)Æc>ŒG„O1žRbü³œH>stream
H‰œ–yTSwÇoÉž�•°Ãc
[€°�5la‘QIBHØADED„ª•2ÖmtFOE�.®cÖ}êÒõ0êè8´×Ž�8G�Ng¦Óïï÷9÷wïïÝß½÷�ó '¥ªµÕ0�Ö ÏJŒÅb¤
2y.-;!à’ÆK°ZÜ ü‹ž^�i½"LÊÀ0ðÿ‰-×é
@8(”µrœ;q®ª7èLöœy¥•&†Qëñq¶4±jž½ç|æ9ÚÄ
�V�³)g�B£0ñiœWו8#©8wÕ©•õ8_Å٥ʨQãüÜ«QÊj@é&»A)/ÇÙgº>'K‚óÈtÕ;\ú”
Ó¥$ÕºF½ZUnÀÜå˜(4TŒ%)ë«”ƒ0C&¯”阤Z£“i˜¿óœ8¦Úbx‘ƒE¡ÁÁBÑ;…ú¯›¿P¦ÞÎӓ̹žAüom?çW=
€x¯Íú·¶Ò-Œ¯Àòæ[›Ëû0ñ¾¾øÎ}ø¦y)7ta¾¾õõõ>j¥ÜÇTÐ7úŸ¿@ï¼ÏÇtÜ›ò`qÊ2™±Ê€™ê&¯®ª6ê±Z�L®Ä„?â_øóyxg)Ë”z¥�ÈçLUáíÖ*ÔuµSkÿSeØO4?׸¸c¯¯Ø°.òò·åÒR´
ß�Þô-•’2ð5ßáÞüÜÏ ú÷Sá>Ó£Vš‹“då`r£¾n~ÏôY &à+`œ�;ÂA4ˆÉ 䀰ÈA9Ð=¨- t�°lÃ`;»Á~pŒƒ�Á ðGp| ®�[`Lƒ‡`<¯ "AˆYA�+äùCb(ЇR¡,¨*�T�2B-Ð
¨ê‡†¡Ðnè÷ÐQètº}MA ï —0Óal»Á¾°Ž�Sàx ¬‚kà&¸^Á£ð>ø0|>_ƒ'á‡ð,ÂG!"F$H:Rˆ”!z¤éF‘Qd?r9‹\A&‘GÈ”ˆrQ¢áhš‹ÊÑ´íE‡Ñ]èaô4z�BgÐ×Á–àE#H ‹*B=¡‹0HØIøˆp†p�0MxJ$ùD1„˜DV›‰½ÄÄÄãÄKÄ»ÄY‰dEò"E�ÒI2’�ÔEÚBÚGúŒt™4MzN¦‘Èþär!YKî ’÷�?%_&ß#¿¢°(®”0J:EAi¤ôQÆ(Ç()Ó”WT6U@� æP+¨íÔ!ê~êêmê�æD¥eÒÔ´å´!ÚïhŸÓ¦h/èº']B/¢éëèÒ�Ó¿¢?a0nŒhF!ÃÀXÇØÍ8ÅøšñÜŒkæc&5S˜µ™�˜6»lö˜Iaº2c˜K™MÌAæ!æEæ#…寒°d¬VÖë(ëk–Íe‹Øél
»—½‡}Ž}ŸCâ¸qâ9
N'çÎ)Î].ÂuæJ¸rî
î÷wšGä xR^¯‡÷[ÞoÆœchžgÞ`>bþ‰ù$á»ñ¥ü*~ÿ ÿ:ÿ¥…�EŒ…Òb�Å~‹ËÏ,m,£-•–Ý–,¯Y¾´Â¬â*6X�[ݱF=3ë·YŸ±~dó ·‘ÛtÛ´¹iÛzÚfÙ6Û~`{ÁvÖÎÞ.ÑNg·Åî”Ý#{¾}´}…ý€ý§ö¸‘j‡‡ÏþŠ™c1X6„�Æfm“�Ž;'_9 œr�:œ8Ýq¦:‹�ËœœO:ϸ8¸¤¹´¸ìu¹éJq»–»nv=ëúÌMà–ï¶ÊmÜí¾ÀR 4 ö
n»3Ü£ÜkÜGݯz=Ä•[=¾ô„=ƒ<Ë=GTB(É/ÙSòƒ,]6*›-•–¾W:#—È7Ë*¢ŠÊe¿ò^YDYÙ}U„j£êAyTù`ù#µD=¬þ¶"©b{ųÊôÊ+¬Ê¯: !kJ4Gµm¥ötµ}uCõ%�—®K7YV³©fFŸ¢ßYÕ.©=bàá?SŒîƕƩºÈº‘ºçõyõ‡Ø
Ú†�ž�kï5%4ý¦m–7Ÿlqlio™Z³lG+ÔZÚz²Í¹³mzyâò]íÔöÊö?uøuôw|¿"űN»Îå�wW&®ÜÛe֥ﺱ*|ÕöÕèjõê‰5k¶¬yÝèþ¢Ç¯g°ç‡^yïkEk‡Öþ¸®lÝD_pß¶õÄõÚõ×7DmØÕÏîoê¿»1mãál {àûMÅ›Î
nßLÝlÜ<9”úO¤[þ˜¸™$™�™üšhšÕ›B›¯œœ‰œ÷�d�Òž@ž®ŸŸ‹Ÿú i Ø¡G¡¶¢&¢–££v£æ¤V¤Ç¥8¥©¦¦‹¦ý§n§à¨R¨Ä©7©©ªª�««u«é¬\¬ÐD¸®-®¡¯¯‹°°u°ê±`±Ö²K²Â³8³®´%´œµµŠ¶¶y¶ð·h·à¸Y¸Ñ¹J¹Âº;ºµ».»§¼!¼›½½�¾
¾„¾ÿ¿z¿õÀpÀìÁgÁãÂ_ÂÛÃXÃÔÄQÄÎÅKÅÈÆFÆÃÇAÇ¿È=ȼÉ:ɹÊ8Ê·Ë6˶Ì5̵Í5͵Î6ζÏ7ϸÐ9кÑ<ѾÒ?ÒÁÓDÓÆÔIÔËÕNÕÑÖUÖØ×\×àØdØèÙlÙñÚvÚûÛ€ÜÜŠÝÝ–ÞÞ¢ß)߯à6à½áDáÌâSâÛãcãëäsäü儿
æ–çç©è2è¼éFéÐê[êåëpëûì†ííœî(î´ï@ïÌðXðåñrñÿòŒóó§ô4ôÂõPõÞömöû÷Šøø¨ù8ùÇúWúçûwüü˜ý)ýºþKþÜÿmÿÿ÷„óû
endstream
endobj
24 0 obj
<>
endobj
25 0 obj
<>
endobj
26 0 obj
<>stream
H‰\UkPWîfèî¤:MtÆt÷.ñc6YA|ásV$*ÑQ0Ìd,@F4æÑ
ö¼A#FXw]+*²”ìV|�ˆ|E àF�ê×õ4{1n+æ‡ö®êêsïùÎã;ßűÀÇñQÉ+SVƧNZa(ÊXž‘W0ù}CÖÆÜŒüg¶(E�+£•1#Ø¡©èà˜ÀÛÿ{‡€’0¨ uáµcXs€ã®]óMŠós²²…´ §M~ÿî{±Âºba‘)¯°`}Na¶�T˜ùŽŸ›+<ßV ä
ùEõçŠìœÁ¨nÖgy¦Ba�AÈÈ-4ä2…œ´žÖÑÑÃ&„¹Â~™1ò»ð¬ð¹5ÏÄ3ýReƒr·ßÓ 6höD*郇ÒI(Gµ,âÀJÀ~uu°Ê·LG‡È@�¨/�®µ°0|0ùÕл‘Rbº—)ÿêŽ�„›#êïôuܾÃ,/UÌ�ÈÂ64€pˆÕo¨{xòk‡¥žsW8e·®�rK.«ÌåyŒîTYË$–öS^ÉiåV‘å¢hå™Å¥(D–ÌK‹*`à!š®KN];%.Å¿;•³Ëv‡]—@Ùœ�ÈÕ–4—uJZÆW:‰²:E×Hze§—g¦”> Ô@ æâùG:ùÐ|Ø…÷ßÔ€ÍfÝÑø½®“ò‰Îr.�´Hb9?�ZPò±1�³;d›WßAº�Û\.žF‘°ñÞ;4ßÂF*H·,»ùj
N;‡*H»$ÚùÊ.KnŽFûË oZD{pÿ¾Ã‡6ìËù“© ˸¿à Oƒ+ÍøS,dɬ§xaöcÍ^ôÛFúdÙ#óP7ØBxeÉiÑÿ‘,—$›Ä£º'-„U’E¿ž~PvYÙwoîƒs}8YÆ‚‚{À^Dt#�ºFNC^$CÈ4ÐñÛ.³“’®A$¶wõ÷·Æ¢´$9vO§î-Œ2ãàèÕ@ç`»„´8*lVÍB:«M²¹m£kS]v·äõŒ†�bèo”M–<ÜuÒ%;Ýü`8å“d+G×WÞPlݸ2¢O£˜n°è(y€"Oœþ·"&·!vÙÜ’éœE¬ËuK)›ÛᑹGÏ~þ�¾ë”)z^Úê‰ãyƒâˆÏ>¥:#U&Û·sÊäឦÝZÖ ›:aÝJx߬>¦œjîoÿt ‚n®>>g'�Ž]GšºtÝ„ô 37—~òvÙ¯°G:v~£ïl5Í›‘RË/&’ʳdÊ*‹^®ƒdzš�³¦/É›º4¾fçÞ¦r̦Æ\¾Mô‹\Ií÷Ÿž×Ó Ý[ïö@ÛqEÛ«QÂ"_Ô&ܤž‡üÝpÈS•‰äó�qd¹C*·ñè¯Ca)í¥º÷UÞª�ÐŽ&�ÏëŠ6ƒ•´.ÔFÒQ³•;an~óGÈTíT¢Øõù’™‡ùPóºKÚDQu™*u:ª¹Ý÷·êïµFÍJ^;Éç»Ò_IdkÝ•ízxýÑUÇ6¡ž>§îùâ:ñæ~8 v(Ñì–å¯Kç!Î{¡ý±¾©¶ÔògÞ#¹]ÝiÊWá´89_Áÿr=â‘.@š ,h_‡(ÐE_D!|1`§%]€0‘o¬oþò´þÜñô)o%e&òôÙ²«°å2ä]�¨¿×ûú¦ÝeÖÃ"1€/UYÍ‚¦
"®§µÌÜË1÷.ìþgËu•Qc‹"¢RPx\ÇífŽy8osê²™:æàÐÊv´º~ëY¥dÌž¶úh‡jÿµ²WÏÔw÷7¦Ï�OÈŒ‹N¬½ÄÑ}jù.xÔ¥Îá¨ä´§o®9¦QÎW³É�µræ€Që•D§M�4êhˆ‘�GYQV22jÕQtTé¯�~Ùå•ùCðÈíéÕÕéZ«,;üúkd•j“ø¡Ñ`d¿† Ã|‚´>²FAQ�–¾féVÜÝxS¿F¡-ì©Sþš#¼×é”ýº”Ïá.wp%¦Êôh´ð#Ì€˜ÿü|ã1kùW¯4ÁoZåù@�£ÉˆBP6„ªÌàiXXÙ£léÁoõÂÏýš{‘�HÂ'jÇC!²QਈG‰*7Eÿ$lx¼oô°Ê–ûÄ_›‹bQôôh4G•¾üa±èíÕüJöAæ™ò9¸™¤M•(þ 3|žÎQõà¬YÅÔÜ�„®—FIÊIò¥CáÃGÃÀ ED‘r¨ˆ‹w”Ýw˜M]‘çÉ*§ËË»aJ
l®Aë'™c0{ÈKXœ.U
;I�Ó©Öf(~BµmªFü´É�¢µV§£Š;¯
ªz¾>,�ª-°P믰©¢Š¨gãb•xæŠòVÍQ|Ä‹f’›h©à™Mf´p3ÚnE«´ÖJÕ
«+á
¤-Rv•æˆ[· ÿ“v?²ãÅM“«¸Ýt¨íNµúÛ¤GÕógJù<ûÃZÃìrÛ)tQEt‹’lû?áUÕ•…í0ý^gÔ'òlŒ¼òÝX¥!ê¸Ä+îÂD…#*‹{P2Fí¦÷4ô&E4š™Œûˆ(Š‚Òˆ
Ú$ š¡›E+I׊©YrÚ¹X5çucF’Lò�jºï=çûÎù¾ï
cÀ‚_@ã6NæÎ»`ó3w@bî…ÀäÀF7Ü…Pˆ]K‡šò#ú E‰FÝ�}X™5jRÚÊ1„ûDuÇg»#;öÜ+jæà‡·¡ùUW¶¯K±ÍÃÝ5�²ä×ü÷ƒó×w߸3Éñ5Ý•ÁVt•¡î>,ï!X]»X,ÐË»\äLªÖäÈh�>íªm!%�a“—?_®rQ¬N·™ð%“IŸÆŸ�Æ‹�v³h?^eÚ�gÅ‘:š¥Šä%“ÆÔσßܾ|ììÂçìI’k̘§T�ƒ@
‹G²Éµtˆø„~®\˜’5'óô…³¹DÌp_K5øF¶Âêm!^(À;¡+x;nêuþÌÚ¥°0§›ÎÏ'°yRíNÆ�Óh&¼³°FžR|#³Y€AO¾�10v¬—¾FÞœ2·úЦªÎÎqTA{/Hˆ¹XuxÛdeÛyµòÊ)GÑ1‚ù¢Àö9k3äk
âîœì]FÎvA°Þª¶K‡ò4ܦ[X#2–¯CƶfØRúí5žŽ£CÚi/˜F¸ö—ú){å^Þé˶@9'²è>öôú¤Ã3B{�Åß�x2µÕžrÆîŠôDïÙ–w¶yãs…2rV5ôÅÍšÎö©”'y,å¢S¦ˆ\‘ª·@Ø-YÙ}(òÁaDg)œFЈ/"`ÖÕ†½{Kü=Ú±~›±{üSÆ¢PÈz%TzµöêC#ïÒ¢i¦²éÊÊq˜†Š˜Û¥úN�£ÃpÞˆF¹ÕÛB¾õb&xUÃÿ3ŸwÅÿ×µnõRË4-nØÜ ? �:‚Ë»]¬É,ò¬¹™–õí½,–ÊI,»P-טŒ:MØÊÀ�6t)°ä:è&7¼Þ
÷Zwùîä;|_¶2É¿É(Ov.’_Ü’pj¢„©l‚„éw£ ß—×Î^8Hf°Ã“Âãâ…é¢6ß`Ô†EchÔ[M¢úT]^�#šoAÁ3WaáùZ´¾iT¥¤ÜüÔé‘3«$¸[ªîÚW䊱ÿáí�¾MÖä…\„ùšo»rfò¶ô,…�¾»iÆ1õ—ß
œeÛ*޶¶žØ0M¤e=ÿuŽ…~q7(#rxzö6ø-ô i†~Tæå¿ƒ�¾&å©CGŠK¶Z½fó¦µkŽm-&üƒô®&åä—õ¸¸kYàtnCà4Tk�ïÝ"%]
ŽúÚ†Æú›ƒö8Vµ0…QŒ-IŒ™�ö¦Šè8�è»ëçŠo†N¼/ž‰]¹eÙ{„?ºÒ
ÎÒŸ'Ÿå›Ÿ:Ï5‹—ÑdÍòk1™õ"÷â/Ûe¥_Ã|,& ÁuW¿!0�Úçþ3¬¼|mY™FU,$¸Éÿ4‹ŽŒkª0tRúPBƒýïÃÂV¤íŒ^™°gß»¸íøÂBÇÔå¬Fqgq“ª%ìuµÚ=²Ç8«µ²üS‹í“ÿͪ¡@g
;Ö6v_! ù‰ªAHà‘�I@—g"jÚoþ�´ë53CÏ,Αª=IZ׎*|+P¸º½Œža§&oˆŠÊ<êqf^¶9z’¥ƒjb�é¬>XqDä·&ʵf)åø}—>‰å+ü¿à2?ìô Òëv¦jÙILÕ�ÚÊØ,öÒC®ÂøRWàתæ3j£³X&
M£¡Ëi…ŽI€>© ̆�À�5~G…ßÁœMÃ/Ó 7)Q¨¬ã|‰mÿðüí_ÝW½R*]5=´ƒ±[¤Xøþ#·1ÿ WX1.¶IŸ�+Qá' B*Á¢æ2jƒ^c"Ûið:œFƒF†öò½*wõùa6£ÖTòF#×3« 8˜M¦À1ÆÚæv×VJß:GI5�P¨,R6årýj‡¥K(ÔÔO:êaì°
HÉõ²†óצ<æ\Ì™Å
-Š—Mhe
-V»Ž,ñ¼ã‰uWÕÕÝ©¼¥°Y6•ÅhÐ($ã�UÑi‰
=³úÒªú¬Z…Õ`À
§1*½Nk!fÔL½}YwC€�F >Mà ŽZ}©�'»w3è©/UYåŸâ€
r›Á¢çcWz-qÐ
r
¶)r_!fC<0Â-ûÖïf>-šÅ˜�F³A /0·�ÅÎKšüû…{Û¶þѾ@ ý'ÅRŽ,ÿïȼ¼ó¾��Û5°‡¼0-Ž€y�-ó@vÄÀ<¥«²ÒåZIJЉq.wá³êßIŸ}ßG¿ÿLvÁ
}=¾ÿ¿@ÿ.Øø?Z÷~÷(÷=÷a÷gû(÷:û~û†ûû:ûgûa÷û=÷†ÍûJû÷÷K÷O÷÷÷H÷G÷ûûLûMûûûI¢ö°³“”¢����’²”†�‚ˆƒsj…o4Z¯òïȯԨ§…ƒ¢”ˆ��”²“‰Ž„Ž•sg‘iû 5HûûÞJ÷€–øm˜÷=–§–ûr› 7ÿ Ì
äÌ“äŽ
÷“øŠvXXc
endstream
endobj
27 0 obj
<>
endobj
28 0 obj
<>stream
H‰\“Ín£0…÷~
/ÛEÅŸ¹·‘R›´Ró£ÉÌpR¤�Cyûñá Ž4H„�`×\’í~·úÙ&?ÃØülOýÐo¡õöèÏý`²Üv};¯wËo{i&“Äɇûuö—ýpMUÙäW|x�ÃÝ>¼tãÑ?šäGè|至}ø³=<Úäp›¦OñÃlS[×¶ó§ô™¾7o“eÚÓ¾‹Ïûùþçüñû>y›/÷eÚ±óשi}h†³7U�ÚVïñ¨�ºÿž—ë´ã©ýh‚©²÷88ME⹩M•§Ë}¼DvdV²‚·ä-xGÞ�ßÈo`æÆ‹©
fÈ,2rÎÉ9¸ `®[`Ý¢$—`!ø™üÙ1Ó!Ó1Ç!Ç1Ç!ÇmȨÑÑßÁßÑßÁßÑßÁ¿¤s ç’™%2Kf–È®+XWX‹ áxÁxáxYƳA-"뾃¹·‚½Ö%¨Kè¼¼y%¿‚é/ðúü…þYß+ö_Y‹¢¥§ÂSé©ðTz*<•ž
O¥§ÂSé©ðTz*<•ž
Ï
ææiŽüþ/hĵãÐ’ñ˱_ýÞÞBˆ¾|^K�£»ûÁ}�Ó8Ù8§ù+À]0å•
endstream
endobj
29 0 obj
<>stream
H‰bd`ab`ddõ
uÓI-KNÌ+ÖuÊÏIIÈÿ�fü!ÂòC†GôOÀï-2¬:¿ŒY¿—|¯Üûý‚#cÿçü‚Ê¢ÌôŒ…�äM#CK…¤J·ü¼’âÜÌ’Ÿ’=Çœ°²b…¢ÔâÔ¢²T `HFf±BP¡Bnb¥B^~‰BRªBbNIjQjŠBfžBb^¥B9P¦hL~i‰BAQf~‘BAjQnfqqf~žB~š=únÁ!•©
)©i t¤Ð�Žî�?^îdœ¿óËNæùb?~ºþI`ûÞü{“èo¹ï-¬ß—³ý¾÷ç’è�Sìßͯgýžø{¢èoµï¿1ëïk‹~Wÿ>ù»Úïɬ|ßkù¦ýÈ›ùÝzÚŠél¿‹æ°¹¹3¾ÛN[>�ãwÑlN¹æÿy8r}ä~8�‡ç»`?/@€”G
endstream
endobj
30 0 obj
<>
endobj
31 0 obj
<>stream
H‰\�ÏjÄ Æï>Åw‹Ùœ%P¶rèšöŒNR¡ebyûŽ6l¡*ã÷ýäsôì)dÐoÝ€¦@žq�;„ç@êÚ‚.]ÝÝb“ÒûšqéiŠÊÐï"®™w8=ø8âYéWöÈ�f8}Þ†3èaKé¤
txœä¡g›^ì‚ +vé½è!ïaþ{Bhký
ã¢Ç5Y‡liFe©Ì“T§�ü?ý ÆÉ}YV¦-Þ¦‘£x�ÛBÉçàÉmÌ’¦N Æ(á}H)&ª,õ#ÀÙÆo0
endstream
endobj
32 0 obj
<>stream
application/pdf
Simlandi_Logo_RGB
2024-02-22T12:59:55-05:00
2024-02-22T12:59:55-05:00
2024-02-22T12:59:55-05:00
Adobe Illustrator 28.2 (Macintosh)
uuid:8d90a0ce-3e06-4140-b532-446d2e12e718
xmp.did:4a3a9405-20d0-4587-9b18-82b734daee6c
uuid:5D20892493BFDB11914A8590D31508C8
proof:pdf
uuid:deca3b67-8cde-d14e-bd15-8aa2af415ca6
xmp.did:67c5ba00-db22-4e35-80dc-10075d922a39
uuid:5D20892493BFDB11914A8590D31508C8
proof:pdf
saved
xmp.iid:181f7003-f9f8-4547-90ab-7bca00eb7708
2022-08-30T11:38:53-04:00
Adobe Illustrator 26.0 (Macintosh)
/
saved
xmp.iid:4a3a9405-20d0-4587-9b18-82b734daee6c
2024-02-22T12:57:26-05:00
Adobe Illustrator 28.2 (Macintosh)
/
Print
AIRobin
Document
Adobe PDF library 17.00
1
False
False
5.000000
2.000000
Inches
Cyan
Magenta
Yellow
Black
Default Swatch Group
0
Black
RGB
PROCESS
35
31
32
Simlandi-Maroon-RGB
PROCESS
100.000000
RGB
118
46
73
Simlandi-DarkTeal-RGB
PROCESS
100.000000
RGB
0
86
122
Simlandi-OverlapGrape-RGB
PROCESS
100.000000
RGB
78
29
62
endstream
endobj
33 0 obj
<>
endobj
1 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
2 0 obj
[/Indexed/DeviceRGB 255 1 0 R]
endobj
3 0 obj
<>
endobj
4 0 obj
<>stream
8;Z]\_$u#N$jBHLIBo4'br<)paXkdjf[]:E-rNJY.Ono]Wr*Z9`!Dd76q,Q?/#QBR
.M_^DQrW[oe:UcD7W`P6IOB;Wm\D(o:!JYCk-FrlJgW@[7;jg"~>
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>stream
2026-01-05T11:57:21-05:00
2026-01-05T11:57:21-05:00
2026-01-05T11:57:21-05:00
Adobe InDesign 21.1 (Macintosh)
uuid:016df165-8a9d-c940-9c9a-efff9f1a688c
xmp.did:b45374b2-785d-4cf8-9130-0432bc48d44a
xmp.id:15c5a0a4-b8ea-4cea-b965-38f10d0c8458
proof:pdf
xmp.iid:f56263a2-9f6b-4a87-9867-2cd2f8d7e36f
xmp.did:398f5dca-129e-4e0a-b065-835e78349086
xmp.did:b45374b2-785d-4cf8-9130-0432bc48d44a
default
converted
from application/x-indesign to application/pdf
Adobe InDesign 21.1 (Macintosh)
/
2026-01-05T11:57:21-05:00
application/pdf
Adobe PDF Library 18.0
False
Mac
Commercially insured patients may be
eligible for GRANIX financial assistance.
1. Print out this savings card.
2. Fill your prescription at the pharmacyand
bring your savings card.
3. See Terms and Conditions below for
additional information.
Pharmacist is required to provide a copy of and review the accompanying GRANIX Patient Savings Program Terms and Conditions with the patient prior to redeeming this offer.
GRANIX (tbo-filgrastim) Injection Patient Savings Program.
Terms and Conditions:
» Subject to program limitations and terms and conditionsthe GRANIX Patient Savings program is available to patients who have a valid GRANIX prescription and who have commercial insurance coverage for GRANIX. No substitutions permitted. Patients with commercial insurance coverage that does not provide formulary coverage for GRANIX are NOT eligible for the Patient Savings program. The Patient Savings program does not cover GRANIX dispensed or administered under commercial insurance as adjudicated under a medical plan.
» Patients enrolled in any state or federally funded healthcare programincluding but not limited toMedicareMedigapMedicaidVADODTRICAREPuerto Rico Government Health Insurance Planand Medicare-eligible patients enrolled in an employer-sponsored health plan or prescription drug benefit program for retireesare NOT eligible for the Patient Savings program.
» Uninsured and cash-paying patients are NOT eligible for the Patient Savings program.
» Eligible Patients may pay as little as $0 on each fill. Annual benefit limits per individual apply and out of pocket expenses may vary. Patients are responsible for all amounts that exceed these Patient Savings program benefit
limits. If the prior authorization is approved by the commercial insurerthen the patient remains eligible for the Patient Savings program. If the prior authorization is denied by the commercial insurerthen the patient is no longer
eligible for the Patient Savings program and may not receive any additional Patient Savings program benefits. If
your insurance coverage changes or if you have any questions regarding your eligibility or benefitsplease call
1-844-218-0443.
» Teva has the right to reduce or eliminate patient benefit amountsbased on factors determined solely by Tevaincluding depending on the terms of a patient’s prescription drug plan and to ensure all program funds are used for the benefit of the patient.
» Data related to a patient’s receipt of Patient Savings program benefits may be collectedanalyzedand shared with CephalonInc.a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd. and its affiliates (“Teva�)for
market research and other purposes (including with the patient’s treating physician towards helping to verify or coordinate insurance coverage or otherwise obtain payment for the patient’s treatment with GRANIX) related to assessing the Patient Savings program. Data shared with Teva will be aggregated and de-identifiedmeaning it
will not identify patients.
» The Patient Savings program is restricted to residents of the United States and United States territories. Patients residing in or receiving treatment in certain states may not be eligible.
» The Patient Savings program is intended for the benefit of patientsnot their insurance plans or other third parties. Patients whose commercial insurance plans do not apply Patient Savings program payments to satisfy patient out-of-pocket cost sharing amounts may not be eligible for the Patient Savings program. Similarlypatients whose commercial insurance plans require use of the Patient Savings program as a condition of the plan waiving some or all of otherwise applicable patient out-of-pocket cost sharing amounts may not be eligible for the Patient Savings program or have a reduced annual maximum program benefit. If you believe your commercial insurance plan may have such limitationsplease call 1-844-218-0443.
» The Patient Savings program is not health insurance. Patients may not seek reimbursement for the value received from the Patient Savings program from any third-party payersincluding a flexible spending account or healthcare savings account. Participating in this program means that you are ensuring you comply with any required disclosure regarding your participation in the Patient Savings program of your insurance carrier or pharmacy benefit manager.
» The Patient Savings program is void if copiedtransferredpurchasedaltered or tradedand where prohibited and restricted by law. The Patient Savings program is not available to residents of Massachusetts. The Patient Savings program is not transferable. No substitutions are permitted. The Patient Savings program may not be soldpurchasedtradedor counterfeited. Void if reproduced. The Patient Savings program benefit cannot be combined with any other financial assistance programfree trialdiscountprescription savings cardor other offer. Teva reserves the right to make eligibility determinationsto set Program benefit maximumsto monitor participationand to changerescindrevokeor discontinue this Patient Savings program at any time without notice. If you have any questions regarding this Patient Savings programyour eligibility or benefits or if you wish to discontinue your participationcall
1-844-218-0443.
» These Terms and Conditions are valid for GRANIX dispensed between 10/1/2022 and 12/31/2023.
Expiration Date: 12/31/2023.
To the Pharmacist:
» By redeeming this Patient Savings programyou are certifying that you understand and agree to comply with the Terms and Conditions above.
» When you apply this offeryou are certifying that you have not submitted and will not submit a claim for reimbursement under any federalstateor other governmental program for this prescription.
» Submit claim to CHANGE HEALTHCARE. If primary coverage existsinput offer information as secondary coverage and transmit using the COB segment of the NCPDP transaction. For questionsplease call the Change Healthcare Help Desk at 1-800-433-4893.
To the Patient:
» By redeeming this Patient Savings programyou are certifying that you understand and agree to comply with the Terms and Conditions above.
Financial assistance
for Granix
Commercially insured and cash-paying
patients may be eligible for GRANIX
financial assistance
Up to $10,000 savings per calendar year.
BIN 004682
PCN CN
Group EC74008003
Member ID 69468968630
EXPIRES: 12/31/2023
$0
Out of
Pocket
© 2022 CephalonInc.a wholly-owned subsidiary of Teva PharmaceuticalsInc. USA. GRX-41457 December 2022
Please see GRANIX Full Prescribing Information.
Please see GRANIX Full Prescribing Information.
S:8.5"
S:11"
T:8.5"
T:11"
B:8.5"
B:11"
S:8.5"
S:11"
T:8.5"
T:11"
B:8.5"
B:11"
0
2072838310
2072838310
TT Slug OTF
TTSlugOTF
OpenType - PS
--
0
002.000
0
4012112768
4012112768
Teva Sans
TevaSans-Regular
OpenType - PS
--
0
1.001
0
213276564
213276564
Teva Sans
TevaSans-Bold
OpenType - PS
--
0
1.001
endstream
endobj
7 0 obj
<>
endobj
xref
0 8
0000000000 65535 f
0000038443 00000 n
0000038955 00000 n
0000039001 00000 n
0000039043 00000 n
0000039396 00000 n
0000039448 00000 n
0000052400 00000 n
trailer
<<8A5D65579A9849F491E1EC15AEA0B1FD>]>>
startxref
116
%%EOF